HEALTH

New mobile app debuts from E.P.T.

BY Allison Cerra

LANGHORNE, Pa. — Insight Pharmaceuticals has launched a mobile application for its E.P.T. brand.

The new E.P.T. ovulation calculator features an easy-to-use interface that’s designed to help users who are trying to get pregnant know when they are most fertile, or simply keep track of their menstrual cycle, the company said. The app — which currently is available for the iPhone, iPad, and iPod Touch, and supports Apple iOS 5 — also comes with 35 fertility tips and is equipped to provide email or calendar reminders on the day before expected ovulation.

"As the first FDA-approved home pregnancy test available to consumers, E.P.T. has held an important role in the lives of many women by providing accurate results for 35 years," said Lauren Schulz, E.P.T. brand manager at Insight Pharmaceuticals. "Recognizing that today women are increasingly on-the-go and online, we wanted to provide a way where women can easily track their cycles and know the most optimal times to try to conceive — right at their fingertips."

The E.P.T. ovulation calculator app can be downloaded via the Apple iTunes app store.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Genomma Lab looks to nominate members to Prestige Brands’ board

BY Allison Cerra

IRVINGTON, N.Y. — Genomma Lab is planning to present a list of candidates to serve on the board of directors of Prestige Brands.

The announcement followed Genomma Lab’s unsolicited proposal to acquire Prestige Brands for $16.60 per share in cash. Although the deal was rejected, Genomma Lab intends to present the list at Prestige Brands’ upcoming annual meeting in June.

"Genomma’s sole purpose in seeking to propose a slate of nominees is to advance its inadequate and highly conditional proposal and to seek to acquire Prestige Brands at the lowest possible price," the company said. "Prestige Brands is committed to maximizing stockholder value, and would be open to compelling, fully financed offers that provide certainty of closing. The Prestige Brands board, comprised of independent, high-quality directors, previously rejected Genomma’s unsolicited highly conditional proposal, and determined that the proposed price is inadequate and the proposal is not in the best interests of the company and its stockholders."

Prestige Brands added that the company will evaluate the notice in accordance with its bylaws and applicable law, and its board will make a recommendation with respect to nominations in due course that is in the best interests of all of the company’s stockholders.

 


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

West Virginia adopts NPLEx system

BY Allison Cerra

WASHINGTON — West Virginia has become the 19th state to require pharmacists and other retailers to be connected through the National Precursor Log Exchange system with the passage of legislation that requires real-time, stop-sale technology to enable the state’s pharmacists to block illegal pseudoephedrine purchases right at the point of sale and provide law enforcement with up-to-the minute criminal data.

The state legislation — Senate Bill 437 — was authored by governor Earl Ray Tomblin and sponsored by Senate president Jeffery Kessler (D-Marshall) and Sen. Mike Hall (R-Putnam). The measure will now head to Gov. Tomblin’s desk for his signature. NPLEx is designed to fight against methamphetamine production and has blocked tens of thousands of illegal sales across the country. The system targets meth criminals while protecting law-abiding consumers’ access to safe and effective medicines containing pseudoephedrine.

The passage of the legislation was praised by the Consumer Healthcare Products Association.

"Gov. Tomblin, Sens. Kessler and Hall, and the West Virginia legislature are to be commended for choosing a proven method for curbing methamphetamine production that targets criminals and protects responsible consumers’ access to popular and reliable cold and allergy medicines," CHPA CEO Scott Melville said. "Once Gov. Tomblin signs SB 437 into law, West Virginia will become the 19th state to implement real-time, stop-sale technology that gives law enforcement officials the upper hand against meth offenders. Passage of SB 437 is a significant victory for West Virginia citizens, employers, law enforcement officials and healthcare providers."


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES